Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

Cells succumbing to stress via regulated cell death (RCD) can initiate an adaptive immune response associated with immunological memory, provided they display sufficient antigenicity and adjuvanticity. Moreover, multiple intracellular and microenvironmental features determine the propensity of RCD t...

Full description

Saved in:
Bibliographic Details
Main Authors: Udo S Gaipl, Dmitriy Zamarin, Felipe Prosper, Francesco M Marincola, Alessandra Cesano, Howard L Kaufman, Laurence Zitvogel, Tim Illidge, Taha Merghoub, Sandra Demaria, Abhishek D Garg, Patrizia Agostinis, James W Hodge, George Coukos, Akseli Hemminki, Öystein Rekdal, Jian Han, John Stagg, Sarah Warren, Lorenzo Galluzzi, Dobrin Draganov, Silvia C Formenti, Mark J Smyth, Radek Špíšek, Michael T Lotze, Takahiro Yamazaki, Guido Kroemer, Daolin Tang, Eric Deutsch, Jitka Fucikova, Sofia R Gameiro, Ilio Vitale, Sandy Adjemian, Aitziber Buqué Martinez, Timothy A Chan, Richard L Edelson, Lucia Gabriele, Encouse Golden, Kevin J Harrington, Dewan Md Sakib Hossain, Michael Karin, Oliver Kepp, Juan Jose Lasarte, Sherene Loi, Gwenola Manic, Alan A Melcher, Karen L Mossman, Maria Rescigno, Chiara Riganti, Antonella Sistigu, Bryan E Strauss, Kazuki Tatsuno, Stefaan W van Gool, Peter Vandenabeele
Format: Article
Language:English
Published: BMJ Publishing Group 2020-05-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/1/e000337.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846172836095328256
author Udo S Gaipl
Dmitriy Zamarin
Felipe Prosper
Francesco M Marincola
Alessandra Cesano
Howard L Kaufman
Laurence Zitvogel
Tim Illidge
Taha Merghoub
Sandra Demaria
Abhishek D Garg
Patrizia Agostinis
James W Hodge
George Coukos
Akseli Hemminki
Öystein Rekdal
Jian Han
John Stagg
Sarah Warren
Lorenzo Galluzzi
Dobrin Draganov
Silvia C Formenti
Mark J Smyth
Radek Špíšek
Michael T Lotze
Takahiro Yamazaki
Guido Kroemer
Daolin Tang
Eric Deutsch
Jitka Fucikova
Sofia R Gameiro
Ilio Vitale
Sandy Adjemian
Aitziber Buqué Martinez
Timothy A Chan
Richard L Edelson
Lucia Gabriele
Encouse Golden
Kevin J Harrington
Dewan Md Sakib Hossain
Michael Karin
Oliver Kepp
Juan Jose Lasarte
Sherene Loi
Gwenola Manic
Alan A Melcher
Karen L Mossman
Maria Rescigno
Chiara Riganti
Antonella Sistigu
Bryan E Strauss
Kazuki Tatsuno
Stefaan W van Gool
Peter Vandenabeele
author_facet Udo S Gaipl
Dmitriy Zamarin
Felipe Prosper
Francesco M Marincola
Alessandra Cesano
Howard L Kaufman
Laurence Zitvogel
Tim Illidge
Taha Merghoub
Sandra Demaria
Abhishek D Garg
Patrizia Agostinis
James W Hodge
George Coukos
Akseli Hemminki
Öystein Rekdal
Jian Han
John Stagg
Sarah Warren
Lorenzo Galluzzi
Dobrin Draganov
Silvia C Formenti
Mark J Smyth
Radek Špíšek
Michael T Lotze
Takahiro Yamazaki
Guido Kroemer
Daolin Tang
Eric Deutsch
Jitka Fucikova
Sofia R Gameiro
Ilio Vitale
Sandy Adjemian
Aitziber Buqué Martinez
Timothy A Chan
Richard L Edelson
Lucia Gabriele
Encouse Golden
Kevin J Harrington
Dewan Md Sakib Hossain
Michael Karin
Oliver Kepp
Juan Jose Lasarte
Sherene Loi
Gwenola Manic
Alan A Melcher
Karen L Mossman
Maria Rescigno
Chiara Riganti
Antonella Sistigu
Bryan E Strauss
Kazuki Tatsuno
Stefaan W van Gool
Peter Vandenabeele
author_sort Udo S Gaipl
collection DOAJ
description Cells succumbing to stress via regulated cell death (RCD) can initiate an adaptive immune response associated with immunological memory, provided they display sufficient antigenicity and adjuvanticity. Moreover, multiple intracellular and microenvironmental features determine the propensity of RCD to drive adaptive immunity. Here, we provide an updated operational definition of immunogenic cell death (ICD), discuss the key factors that dictate the ability of dying cells to drive an adaptive immune response, summarize experimental assays that are currently available for the assessment of ICD in vitro and in vivo, and formulate guidelines for their interpretation.
format Article
id doaj-art-a9d90895f1e544d9989ad2cde51f79c0
institution Kabale University
issn 2051-1426
language English
publishDate 2020-05-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj-art-a9d90895f1e544d9989ad2cde51f79c02024-11-09T02:05:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-05-018110.1136/jitc-2019-000337Consensus guidelines for the definition, detection and interpretation of immunogenic cell deathUdo S Gaipl0Dmitriy Zamarin1Felipe Prosper2Francesco M Marincola3Alessandra Cesano4Howard L Kaufman5Laurence Zitvogel6Tim Illidge7Taha Merghoub8Sandra Demaria9Abhishek D Garg10Patrizia Agostinis11James W Hodge12George Coukos13Akseli Hemminki14Öystein Rekdal15Jian Han16John Stagg17Sarah Warren18Lorenzo Galluzzi19Dobrin Draganov20Silvia C Formenti21Mark J Smyth22Radek Špíšek23Michael T Lotze24Takahiro Yamazaki25Guido Kroemer26Daolin Tang27Eric Deutsch28Jitka Fucikova29Sofia R Gameiro30Ilio Vitale31Sandy Adjemian32Aitziber Buqué Martinez33Timothy A Chan34Richard L Edelson35Lucia Gabriele36Encouse Golden37Kevin J Harrington38Dewan Md Sakib Hossain39Michael Karin40Oliver Kepp41Juan Jose Lasarte42Sherene Loi43Gwenola Manic44Alan A Melcher45Karen L Mossman46Maria Rescigno47Chiara Riganti48Antonella Sistigu49Bryan E Strauss50Kazuki Tatsuno51Stefaan W van Gool52Peter Vandenabeele53Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany12 Department of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USACancer Center Universidad de Navarra (CCUN), Pamplona, SpainAff8 grid.467063.00000000403974222Research, Sidra Medical and Research Center Doha QatarAff2 NanoString, Inc 500 Fairview Avenue North 98109 Seattle WA USADepartment of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA1Gustave Roussy, Villejuif, Ile-de-France, FranceAff1 grid.5379.80000000121662407University of Manchester Manchester United Kingdom1Weill Cornell Medical and Graduate Schools, New York, New York, USADepartment of Radiation Oncology, Weill Cornell Medical College, New York, New York, USALaboratory of Cell Stress & Immunity, Department of Cellular & Molecular Medicine, KU Leuven, Leuven, BelgiumDepartment of Cellular and Molecular Medicine, Cell Death Research and Therapy Laboratory, KU Leuven, BelgiumCenter for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USADepartment of Oncology, Ludwig Institute for Cancer Research Lausanne, Lausanne University Hospital and University of Lausanne, Lausanne, Vaud, Switzerland2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, FinlandAff1 Lytixbiopharma, Oslo, Norway Oslo NorwayShanxi Dayi Hospital, Rheumatology, Taiyuan, ChinaFaculty of Pharmacy, Centre Hospitalier de L`Universite de Montreal, Montreal, Quebec, CanadaGilead Sciences, Seattle, Washington, USADepartment of Radiation Oncology, Weill Cornell Medical College, New York, NY, USAAff33 Calidi Biotherapeutics San Diego CA USAAff2 grid.137628.90000000121698901Radiation OncologyNYU School of Medicine New York NY USAAff2 grid.1055.10000000403978434Cancer ImmunologyPeter MacCallum Cancer Centre Melbourne VIC AustraliaSotio Biotech, Prague, Czech RepublicUPMC Hillman Cancer Center and University of Pittsburgh, Pittsburgh, Pennsylvania, USA1Weill Cornell Medical College, New York, NY, USA1Gustave Roussy, Villejuif, Ile-de-France, FranceAff4 grid.21925.3d0000000419369000Department of SurgeryUniversity of Pittsburgh Pittsburgh PA USAINSERM U1030, Gustave Roussy, Université Paris-Saclay, Villejuif, FranceSotio Biotech, Prague, Czech RepublicCenter for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA6 IIGM - Italian Institute for Genomic Medicine, c/o IRCSS, Candiolo, Torino, Italy9 VIB Center for Inflammation Research (IRC), Ghent, Belgium1 Department of Radiation Oncology, Weill Cornell Medical College, New York City, New York, USAHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA4 Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA24 Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy1 Department of Radiation Oncology, Weill Cornell Medical College, New York City, New York, USADivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK32 Merck & Co. Inc, Kenilworth, New Jersey, USA34 Department of Pharmacology and Pathology, University of California at San Diego (UCSD) School of Medicine, La Jolla, California, USAMetabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, FranceImmunology and Immunotherapy Program, Center for Applied Medical Research (CIMA), University of Navarra, IdISNA, Pamplona, Spain18 Division of Cancer Research, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia6 IIGM - Italian Institute for Genomic Medicine, c/o IRCSS, Candiolo, Torino, ItalyDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UKDepartment of Medicine, McMaster University, Hamilton, Ontario, CanadaIRCSS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy1University of Torino, Torino, Piemonte, Italy63 UOSD Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy69 Centro de Investigação Translacional em Oncologia/LIM24, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brasil4 Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA71 Immun-Onkologisches Zentrum Köln, Cologne, Germany9 VIB Center for Inflammation Research (IRC), Ghent, BelgiumCells succumbing to stress via regulated cell death (RCD) can initiate an adaptive immune response associated with immunological memory, provided they display sufficient antigenicity and adjuvanticity. Moreover, multiple intracellular and microenvironmental features determine the propensity of RCD to drive adaptive immunity. Here, we provide an updated operational definition of immunogenic cell death (ICD), discuss the key factors that dictate the ability of dying cells to drive an adaptive immune response, summarize experimental assays that are currently available for the assessment of ICD in vitro and in vivo, and formulate guidelines for their interpretation.https://jitc.bmj.com/content/8/1/e000337.full
spellingShingle Udo S Gaipl
Dmitriy Zamarin
Felipe Prosper
Francesco M Marincola
Alessandra Cesano
Howard L Kaufman
Laurence Zitvogel
Tim Illidge
Taha Merghoub
Sandra Demaria
Abhishek D Garg
Patrizia Agostinis
James W Hodge
George Coukos
Akseli Hemminki
Öystein Rekdal
Jian Han
John Stagg
Sarah Warren
Lorenzo Galluzzi
Dobrin Draganov
Silvia C Formenti
Mark J Smyth
Radek Špíšek
Michael T Lotze
Takahiro Yamazaki
Guido Kroemer
Daolin Tang
Eric Deutsch
Jitka Fucikova
Sofia R Gameiro
Ilio Vitale
Sandy Adjemian
Aitziber Buqué Martinez
Timothy A Chan
Richard L Edelson
Lucia Gabriele
Encouse Golden
Kevin J Harrington
Dewan Md Sakib Hossain
Michael Karin
Oliver Kepp
Juan Jose Lasarte
Sherene Loi
Gwenola Manic
Alan A Melcher
Karen L Mossman
Maria Rescigno
Chiara Riganti
Antonella Sistigu
Bryan E Strauss
Kazuki Tatsuno
Stefaan W van Gool
Peter Vandenabeele
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Journal for ImmunoTherapy of Cancer
title Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
title_full Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
title_fullStr Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
title_full_unstemmed Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
title_short Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
title_sort consensus guidelines for the definition detection and interpretation of immunogenic cell death
url https://jitc.bmj.com/content/8/1/e000337.full
work_keys_str_mv AT udosgaipl consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT dmitriyzamarin consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT felipeprosper consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT francescommarincola consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT alessandracesano consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT howardlkaufman consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT laurencezitvogel consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT timillidge consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT tahamerghoub consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT sandrademaria consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT abhishekdgarg consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT patriziaagostinis consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT jameswhodge consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT georgecoukos consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT akselihemminki consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT oysteinrekdal consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT jianhan consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT johnstagg consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT sarahwarren consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT lorenzogalluzzi consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT dobrindraganov consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT silviacformenti consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT markjsmyth consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT radekspisek consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT michaeltlotze consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT takahiroyamazaki consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT guidokroemer consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT daolintang consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT ericdeutsch consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT jitkafucikova consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT sofiargameiro consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT iliovitale consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT sandyadjemian consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT aitziberbuquemartinez consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT timothyachan consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT richardledelson consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT luciagabriele consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT encousegolden consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT kevinjharrington consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT dewanmdsakibhossain consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT michaelkarin consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT oliverkepp consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT juanjoselasarte consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT shereneloi consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT gwenolamanic consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT alanamelcher consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT karenlmossman consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT mariarescigno consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT chiarariganti consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT antonellasistigu consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT bryanestrauss consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT kazukitatsuno consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT stefaanwvangool consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath
AT petervandenabeele consensusguidelinesforthedefinitiondetectionandinterpretationofimmunogeniccelldeath